Home>US Stocks>Seattle Genetics, Inc.
shareSHARE

SGEN

Seattle Genetics, Inc.

Performance

Today’s Low
NA
    Today’s High
    NA
    52W Low
    NA
      52W High
      NA
      Open PricePrev. CloseVolumeAvg. Volume
      $0.00$0.00NANA

      Company Statistics

      Market CapP/B RatioP/E RatioEnterprise Value
      $28.42 B8.3043.00$28.1 B
      Div. YieldBook ValueEPS(TTM)ROE
      NA18.91-0.67NA

      About the Company

      Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgki
      Organisation
      Seattle Genetics, Inc.
      Industry
      Biotechnology
      Headquarters
      Bothell, WA
      ⓒ 2016-2021 Groww. All rights reserved, Built with in India
      ABOUT GROWW
      keyboard_arrow_down